Your browser doesn't support javascript.
loading
The discovery and evaluation of [18F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement.
Donnelly, David J; Kim, Joonyoung; Tran, Tritin; Scola, Paul M; Tenney, Daniel; Pena, Adrienne; Petrone, Thomas; Zhang, Yunhui; Boy, Kenneth M; Poss, Michael A; Cole, Erin L; Soars, Matthew G; Johnson, Benjamin M; Cohen, Daniel; Batalla, Daniel; Chow, Patrick L; Shorts, Andrea Olga; Du, Shuyan; Meanwell, Nicholas A; Bonacorsi, Samuel J.
Affiliation
  • Donnelly DJ; Small Molecule Drug Discovery-PET Radiochemical Synthesis, Bristol Myers Squibb Research and Early Development, P.O. Box 4000, Princeton, NJ, 08543, USA. david.donnelly@bms.com.
  • Kim J; Imaging, Bristol Myers Squibb, Princeton, USA.
  • Tran T; Small Molecule Drug Discovery-PET Radiochemical Synthesis, Bristol Myers Squibb Research and Early Development, P.O. Box 4000, Princeton, NJ, 08543, USA.
  • Scola PM; Small Molecule Drug Discovery, Bristol Myers Squibb, Cambridge, USA.
  • Tenney D; Biology, Bristol Myers Squibb, Princeton, USA.
  • Pena A; Imaging, Bristol Myers Squibb, Princeton, USA.
  • Petrone T; Imaging, Bristol Myers Squibb, Princeton, USA.
  • Zhang Y; Small Molecule Drug Discovery, Bristol Myers Squibb, Cambridge, USA.
  • Boy KM; Small Molecule Drug Discovery, Bristol Myers Squibb, Cambridge, USA.
  • Poss MA; Small Molecule Drug Discovery, Bristol Myers Squibb, Princeton, USA.
  • Cole EL; Small Molecule Drug Discovery-PET Radiochemical Synthesis, Bristol Myers Squibb Research and Early Development, P.O. Box 4000, Princeton, NJ, 08543, USA.
  • Soars MG; Pharmaceutical Candidate Optimization, Bristol Myers Squibb, Cambridge, USA.
  • Johnson BM; Pharmaceutical Candidate Optimization, Bristol Myers Squibb, Cambridge, USA.
  • Cohen D; Biologics and Platforms, Bristol Myers Squibb, Princeton, USA.
  • Batalla D; Small Molecule Drug Discovery-PET Radiochemical Synthesis, Bristol Myers Squibb Research and Early Development, P.O. Box 4000, Princeton, NJ, 08543, USA.
  • Chow PL; Imaging, Bristol Myers Squibb, Princeton, USA.
  • Shorts AO; Imaging, Bristol Myers Squibb, Princeton, USA.
  • Du S; Imaging, Bristol Myers Squibb, Princeton, USA.
  • Meanwell NA; Small Molecule Drug Discovery, Bristol Myers Squibb, Princeton, USA.
  • Bonacorsi SJ; Small Molecule Drug Discovery-PET Radiochemical Synthesis, Bristol Myers Squibb Research and Early Development, P.O. Box 4000, Princeton, NJ, 08543, USA.
Eur J Nucl Med Mol Imaging ; 51(4): 978-990, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38049658
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Fluorine Radioisotopes / Carcinoma, Non-Small-Cell Lung / Fibronectin Type III Domain / Lung Neoplasms Limits: Animals / Humans Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2024 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Fluorine Radioisotopes / Carcinoma, Non-Small-Cell Lung / Fibronectin Type III Domain / Lung Neoplasms Limits: Animals / Humans Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2024 Type: Article Affiliation country: United States